Back to top

Intercept Pharmaceuticals Inc. (ICPT) Enters Overbought Territory
December 16, 2013

Read MoreHide Full Article
Intercept Pharmaceuticals Inc. (ICPT) has moved higher as of late, but there could definitely be trouble on the horizon for this company. That is because ICPT is now in overbought territory with an RSI value of 71.5. Furthermore, Intercept Pharmaceuticals Inc. currently has a Zacks Rank #4 (Sell), suggesting that investors may want to consider exiting this stock now before it falls back to Earth.



In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Intercept Pharmaceuticals, Inc. (ICPT) - free report >>


More from Zacks Tale of the Tape

You May Like